157 related articles for article (PubMed ID: 7992315)
21. Repeated dosing with the peroxisome proliferator clofibrate decreases the toxicity of model hepatotoxic agents in male mice.
Manautou JE; Silva VM; Hennig GE; Whiteley HE
Toxicology; 1998 May; 127(1-3):1-10. PubMed ID: 9699788
[TBL] [Abstract][Full Text] [Related]
22. Role of the nuclear receptor pregnane X receptor in acetaminophen hepatotoxicity.
Wolf KK; Wood SG; Hunt JA; Walton-Strong BW; Yasuda K; Lan L; Duan SX; Hao Q; Wrighton SA; Jeffery EH; Evans RM; Szakacs JG; von Moltke LL; Greenblatt DJ; Court MH; Schuetz EG; Sinclair PR; Sinclair JF
Drug Metab Dispos; 2005 Dec; 33(12):1827-36. PubMed ID: 16141365
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of protection by melatonin against acetaminophen-induced liver injury in mice.
Matsura T; Nishida T; Togawa A; Horie S; Kusumoto C; Ohata S; Nakada J; Ishibe Y; Yamada K; Ohta Y
J Pineal Res; 2006 Oct; 41(3):211-9. PubMed ID: 16948781
[TBL] [Abstract][Full Text] [Related]
24. Potential roles of hepatic heat shock protein 25 and 70i in protection of mice against acetaminophen-induced liver injury.
Sumioka I; Matsura T; Kai M; Yamada K
Life Sci; 2004 Apr; 74(20):2551-61. PubMed ID: 15010265
[TBL] [Abstract][Full Text] [Related]
25. Phenylpropanolamine potentiation of acetaminophen-induced hepatotoxicity: evidence for a glutathione-dependent mechanism.
James RC; Harbison RD; Roberts SM
Toxicol Appl Pharmacol; 1993 Feb; 118(2):159-68. PubMed ID: 8382844
[TBL] [Abstract][Full Text] [Related]
26. Inhibition by ranitidine of acetaminophen conjugation and its possible role in ranitidine potentiation of acetaminophen-induced hepatotoxicity.
Rogers SA; Gale KC; Newton JF; Dent JG; Leonard TB
J Pharmacol Exp Ther; 1988 Jun; 245(3):887-94. PubMed ID: 3133464
[TBL] [Abstract][Full Text] [Related]
27. Hepatic microsomal enzyme induction, beta-oxidation, and cell proliferation following administration of clofibrate, gemfibrozil, or bezafibrate in the CD rat.
Amacher DE; Beck R; Schomaker SJ; Kenny CV
Toxicol Appl Pharmacol; 1997 Jan; 142(1):143-50. PubMed ID: 9007043
[TBL] [Abstract][Full Text] [Related]
28. Mechanism of acetaminophen-induced hepatotoxicity: covalent binding versus oxidative stress.
Gibson JD; Pumford NR; Samokyszyn VM; Hinson JA
Chem Res Toxicol; 1996; 9(3):580-5. PubMed ID: 8728501
[TBL] [Abstract][Full Text] [Related]
29. Identification of a 54-kDa mitochondrial acetaminophen-binding protein as aldehyde dehydrogenase.
Landin JS; Cohen SD; Khairallah EA
Toxicol Appl Pharmacol; 1996 Nov; 141(1):299-307. PubMed ID: 8917703
[TBL] [Abstract][Full Text] [Related]
30. The target portion of acetaminophen induced hepatotoxicity in rats: modification by thiol compounds.
Hirayama C; Murawaki Y; Yamada S; Aoto Y; Ikeda F
Res Commun Chem Pathol Pharmacol; 1983 Dec; 42(3):431-48. PubMed ID: 6665301
[TBL] [Abstract][Full Text] [Related]
31. Influence of feeding schedule on 24-h rhythm of hepatotoxicity induced by acetaminophen in mice.
Matsunaga N; Nakamura N; Yoneda N; Qin T; Terazono H; To H; Higuchi S; Ohdo S
J Pharmacol Exp Ther; 2004 Nov; 311(2):594-600. PubMed ID: 15205452
[TBL] [Abstract][Full Text] [Related]
32. Differential gene expression in mouse liver associated with the hepatoprotective effect of clofibrate.
Moffit JS; Koza-Taylor PH; Holland RD; Thibodeau MS; Beger RD; Lawton MP; Manautou JE
Toxicol Appl Pharmacol; 2007 Jul; 222(2):169-79. PubMed ID: 17585979
[TBL] [Abstract][Full Text] [Related]
33. Influence of acetaminophen and trichloroethylene on liver cytochrome P450-dependent monooxygenase system.
Plewka A; Zielińska-Psuja B; Kowalówka-Zawieja J; Nowaczyk-Dura G; Plewka D; Wiaderkiewicz A; Kamiński M; Orłowski J
Acta Biochim Pol; 2000; 47(4):1129-36. PubMed ID: 11996102
[TBL] [Abstract][Full Text] [Related]
34. Effect of N-acetylcysteine on heat shock protein induction by acetaminophen in mouse liver.
Salminen WF; Voellmy R; Roberts SM
J Pharmacol Exp Ther; 1998 Jul; 286(1):519-24. PubMed ID: 9655897
[TBL] [Abstract][Full Text] [Related]
35. Two-dimensional database of mouse liver proteins: changes in hepatic protein levels following treatment with acetaminophen or its nontoxic regioisomer 3-acetamidophenol.
Fountoulakis M; Berndt P; Boelsterli UA; Crameri F; Winter M; Albertini S; Suter L
Electrophoresis; 2000 Jun; 21(11):2148-61. PubMed ID: 10892726
[TBL] [Abstract][Full Text] [Related]
36. Hepatic protein arylation, glutathione depletion, and metabolite profiles of acetaminophen and a non-hepatotoxic regioisomer, 3'-hydroxyacetanilide, in the mouse.
Rashed MS; Myers TG; Nelson SD
Drug Metab Dispos; 1990; 18(5):765-70. PubMed ID: 1981734
[TBL] [Abstract][Full Text] [Related]
37. Additive protection of cimetidine and N-acetylcysteine treatment against acetaminophen-induced hepatic necrosis in the rat.
Speeg KV; Mitchell MC; Maldonado AL
J Pharmacol Exp Ther; 1985 Sep; 234(3):550-4. PubMed ID: 4032281
[TBL] [Abstract][Full Text] [Related]
38. Effects of clofibrate and indocyanine green on the hepatobiliary disposition of acetaminophen and its metabolites in male CD-1 mice.
Chen C; Hennig GE; McCann DJ; Manautou JE
Xenobiotica; 2000 Nov; 30(11):1019-32. PubMed ID: 11197064
[TBL] [Abstract][Full Text] [Related]
39. Clofibrate-induced in vitro hepatoprotection against acetaminophen is not due to altered glutathione homeostasis.
Nicholls-Grzemski FA; Calder IC; Priestly BG; Burcham PC
Toxicol Sci; 2000 Jul; 56(1):220-8. PubMed ID: 10869471
[TBL] [Abstract][Full Text] [Related]
40. Repeat exposure to incremental doses of acetaminophen provides protection against acetaminophen-induced lethality in mice: an explanation for high acetaminophen dosage in humans without hepatic injury.
Shayiq RM; Roberts DW; Rothstein K; Snawder JE; Benson W; Ma X; Black M
Hepatology; 1999 Feb; 29(2):451-63. PubMed ID: 9918922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
